Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Terminated 3Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 2Astrocytoma 1

Interventions

Temozolomide 10Specimen Handling 6Radiotherapy 6Magnetic Resonance Spectroscopy 6pembrolizumab 3Bevacizumab 3trametinib 2Surgical Procedures, Operative 2Radiation 2Magnetic Resonance Imaging 2Leukapheresis 2Genetic Therapy 2Fluorodeoxyglucose F18 2Biopsy 2vorasidenib 1trastuzumab deruxtecan 1ribociclib 1regorafenib 1olutasidenib 1mirdametinib 1lorlatinib 1dabrafenib 1apixaban 1aflibercept 1abexinostat 1Vinblastine 1Tretinoin 1Therapies, Investigational 1Restraint, Physical 1Re-Irradiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Astrocytoma × Flucytosine × Clear all
NCT06264388 2026-05-28

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

University of Miami

Phase 2 Recruiting
33 enrolled
CNS

Astrocytoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡